Cargando…

Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis

BACKGROUND: Patients with first-episode psychosis or early-phase schizophrenia are susceptible to olanzapine-associated weight gain and cardiometabolic dysregulation. This meta-analysis characterized weight and metabolic effects observed during olanzapine treatment in randomized clinical trials in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Correll, Christoph U, Højlund, Mikkel, Graham, Christine, Todtenkopf, Mark S, McDonnell, David, Simmons, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388390/ https://www.ncbi.nlm.nih.gov/pubmed/37326421 http://dx.doi.org/10.1093/ijnp/pyad029

Ejemplares similares

Comment on “Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review”
por: Todtenkopf, Mark S., et al.
Publicado: (2023)

S226. A STUDY COMPARING WEIGHT GAIN FROM ALKS 3831 TO OLANZAPINE IN EARLY-ILLNESS YOUNG ADULTS WITH SCHIZOPHRENIFORM, SCHIZOPHRENIA, OR BIPOLAR I DISORDER
por: Simmons, Adam, et al.
Publicado: (2018)

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
por: Citrome, Leslie, et al.
Publicado: (2019)

Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study
por: Correll, Christoph U, et al.
Publicado: (2022)

Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates
por: Cunningham, Jacobi I, et al.
Publicado: (2019)

Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
por: Huang, Jing, et al.
Publicado: (2020)

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
por: Fitzgerald, Ita, et al.
Publicado: (2021)

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
por: Huang, Jing, et al.
Publicado: (2020)

Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia
por: Tsuneyama, Nobuto, et al.
Publicado: (2016)

An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder
por: Citrome, Leslie, et al.
Publicado: (2021)

Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report
por: Ifteni, Petru, et al.
Publicado: (2014)

Combining samidorphan with olanzapine to mitigate weight gain as a side effect in schizophrenia treatment
por: Grywińska, Weronika B., et al.
Publicado: (2023)

Weight gain with olanzapine: Drug, gender or age?
por: Jain, Sanjay, et al.
Publicado: (2006)

The Effect of Ranitidine on Olanzapine-Induced Weight Gain
por: Ranjbar, Fatemeh, et al.
Publicado: (2013)

Insulin and glucose metabolism with olanzapine and a combination of olanzapine and samidorphan: exploratory phase 1 results in healthy volunteers
por: Toledo, Frederico G. S., et al.
Publicado: (2021)

Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials
por: Huang, Jing, et al.
Publicado: (2022)

Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report
por: Okazaki, Kosuke, et al.
Publicado: (2017)

Metformin Attenuates Liver Fat Content: Finding from Schizophrenia Patients with Olanzapine-induced Weight Gain
por: Wang, Li, et al.
Publicado: (2020)

Prodromal phase and first episode psychosis in schizophrenia: early signs and diagnosis
por: Buciuc, A.-G., et al.
Publicado: (2022)

Olanzapine and its use for methamphetamine-induced psychosis
por: Nazir, S., et al.
Publicado: (2022)

Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats
por: Hu, Yueshan, et al.
Publicado: (2014)

Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder
por: Lipkovich, Ilya, et al.
Publicado: (2008)

Reducing weight gain in people with schizophrenia, schizoaffective disorder, and first episode psychosis: describing the process of developing the STructured lifestyle Education for People With SchizophrEnia (STEPWISE) intervention
por: Carey, Marian E., et al.
Publicado: (2018)

Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use
por: Mhalla, Ahmed, et al.
Publicado: (2017)

The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse
por: Morgan, Andrew P., et al.
Publicado: (2014)

Olanzapine: Worsening of obsessive compulsive disorder and weight gain: case report
Publicado: (2022)

Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain
por: Qian, Li, et al.
Publicado: (2023)

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
por: Ascher-Svanum, Haya, et al.
Publicado: (2014)

Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment
por: Lian, Jiamei, et al.
Publicado: (2014)

Comparison of olanzapine-induced weight gain and metabolism abnormalities between topiramate and vitamin C in patients with schizophrenia: a preliminary study
por: Zhang, Jinling, et al.
Publicado: (2023)

Lifestyle Interventions in Preventing Excess Weight Gain in First Episode of Psychosis (FEP): A Systematic Review
por: Adeoye, Margret, et al.
Publicado: (2023)

Impact of low‐dose quetiapine‐use on glycosylated hemoglobin, triglyceride and cholesterol levels
por: Højlund, Mikkel, et al.
Publicado: (2022)

Association Between Weight Gain and Remission Status at 3 Months in First-Episode Schizophrenia
por: Oh, Nicholas, et al.
Publicado: (2016)

The psychological journey of weight gain in psychosis
por: Waite, Felicity, et al.
Publicado: (2022)

Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain
por: Weston-Green, Katrina, et al.
Publicado: (2012)

Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review
por: Laguado, S. Andrea, et al.
Publicado: (2022)

Effects of olanzapine on cytokine profile and brain-derived neurotrophic factor in drug-naive subjects with first-episode psychosis
por: Hatziagelaki, Erifili, et al.
Publicado: (2019)

A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection
por: Atkins, Susan, et al.
Publicado: (2014)

Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia
por: Stefanou, Maria-Ioanna, et al.
Publicado: (2020)

Association of Low-Dose Quetiapine and Diabetes
por: Højlund, Mikkel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s5fa2ejavk1elf7g920i39icli